Changes ahead for the national screening system
Changes ahead for the national screening system
Details of changes to the national screening system from 1 October, due to the closure of Public Health England.
Details of changes to the national screening system from 1 October, due to the closure of Public Health England.
March was a busy month for the NHS Newborn Blood Spot (NBS) Screening Programme and we’re now delighted to announce the publication of some great new resources.
We are changing the way we store and distribute leaflets and other printed materials for our cancer screening programmes. This will affect all our clients who order our breast, cervical and bowel cancer screening resources.
Antenatal screening for rubella (German measles) susceptibility stops on 1 April 2016.
Every year, we, the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme, publish a data report, which evaluates the performance of the programme.
PHE Screening has published an updated information pack to help GPs and primary care professionals advise well men aged 50 and over about prostate specific antigen (PSA) testing for prostate cancer.
We, the sickle cell and thalassaemia (SCT) screening programme, are launching an exciting new project which aims to engage the public and service users. This will help improve how we deliver screening for sickle cell and thalassaemia.
Diabetes UK estimates that more than 4 million people are living with diabetes in the UK. That number has been increasing by around 5% a year, which underlines the scale of the challenge facing local diabetic eye screening programmes that …
We at the sickle cell and thalassemia screening programme laboratory support service receive many interesting questions from our service users. These often fall into themes so we thought it would be useful to share some of this information with the …
During March we are mailing out copies of the new print run of the 'Screening tests for you and your baby' booklet to every NHS trust in England that has a maternity unit.
We use key performance indicators (KPIs) to measure and drive improvements in the NHS screening programmes.